Barclays Appoints Naeem Merchant as a Managing Director in Healthcare Investment Banking
September 16 2021 - 11:30AM
Business Wire
Barclays announces the appointment of Naeem Merchant as a
Managing Director in Healthcare Investment Banking. Mr. Merchant
will be based in New York, and will focus on the Pharmaceutical
Services and IT sectors. He will report to Rick Landgarten, Global
Head of Healthcare & Real Estate Groups at Barclays.
Mr. Merchant joins Barclays from Greenhill & Co. where he
was a Managing Director focused on Pharmaceutical Services. He
started his investment banking career at Lehman Brothers fourteen
years ago. Mr. Merchant has led the origination and execution of a
number of high-profile transactions during his career. He has deep
domain expertise, and strategic and investor relationships, across
the Pharmaceutical Services and IT sectors, including providers of
technology and services supporting pharmaceutical research and
development, manufacturing and distribution, and
commercialization.
“We are delighted to welcome Naeem back to Barclays and to our
Healthcare team. His deep industry relationships and extensive
transactional experience will generate tremendous value for our
clients,” said Rick Landgarten, Global Head of Healthcare &
Real Estate Groups. “Naeem’s appointment is further evidence of our
dedication to investing in top level talent in order to enable us
to continue to build on our successes and strong momentum in our
Healthcare franchise.”
Barclays has performed lead roles in a number of recent
transactions of note in the Healthcare Banking space, including
serving as financial advisor to Thermo Fisher Scientific on their
pending $21bn acquisition of PPD, and acting as financial advisor
to Centene Corporation in the company’s $3.1bn acquisition of
Magellan Health, Inc. Barclays acted as financial advisor to
Kindred at Home on their sale to Humana, and served as financial
advisor to HMS on the company’s sale to Veritas Capital-backed
Gainwell Technologies for $3.4bn. In addition, Barclays has
performed key roles in several recent IPOs of note, including
serving as a senior active bookrunner on a $649mm IPO for Signify
Health, Inc., as an active bookrunner on a $924mm IPO for Bright
Health Group, Inc., and as an active bookrunner on a $1.3bn IPO for
GoodRx Holdings, Inc.
Mr. Merchant will start at Barclays in October 2021.
Barclays is a British universal bank. We are diversified by
business, by different types of customer and client, and geography.
Our businesses include consumer banking and payments operations
around the world, as well as a top-tier, full service, global
corporate and investment bank, all of which are supported by our
service company which provides technology, operations and
functional services across the Group. For further information about
Barclays, please visit our website www.barclays.com. Barclays
offers investment banking products and services in the US through
Barclays Capital Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210916005600/en/
Andrew Smith +1 212 412 7521 andrew.x.smith@barclays.com
Barclays (NYSE:BCS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Barclays (NYSE:BCS)
Historical Stock Chart
From Sep 2023 to Sep 2024